CStone Pharmaceuticals
Yi Ting Chang is an experienced Quality Assurance Manager at CStone Pharmaceuticals. Previously, Yi Ting worked as a Clinical Research Project Manager at Protech Pharmaservices Corporation, specializing in Clinical Pharmacology Research. With a Master's degree in Physiology and Pharmacology from Chang Gung University and a Bachelor's degree in Public Health from Taipei Medical University, Yi Ting has a strong background in research and healthcare. Throughout the years, Yi Ting has also held various roles such as Account Specialist, Clinical Trial Assistant, and Research Assistant in different organizations, showcasing a diverse skill set in the pharmaceutical and healthcare industry.
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.